Stock events for National Research Corp. (NRC)
Over the past six months, NRC Health announced its Q1 2025 results, showing a sequential increase in total recurring contract value and a new share repurchase program. The stock price declined, hitting a 52-week low, but the company declared a quarterly cash dividend. National Research Corporation acquired Nobl, Inc. Shane Harrison was appointed as the incoming Executive Vice President and Chief Financial Officer. NRC Health announced its Q3 2025 results, reporting a profit and revenue increase, along with recurring contract value growth. The company repurchased shares and returned capital to shareholders through dividends and stock repurchases.
Demand Seasonality affecting National Research Corp.’s stock price
Specific information regarding the demand seasonality for National Research Corp.'s products and services was not explicitly detailed in the provided search results. There is no direct indication of seasonal fluctuations in demand for NRC Health's subscription-based analytics and insight solutions.
Overview of National Research Corp.’s business
National Research Corp., now known as NRC Health, is a healthcare company that provides analytics and insights to improve patient and employee experiences. The company offers subscription-based solutions that deliver actionable information and analysis to healthcare organizations, focusing on areas such as patient experience, employee engagement, and reputation management. Their major products and services include patient experience solutions, employee experience solutions, physician engagement solutions, market experience solutions, reputation solutions, healthcare analytics & data solutions, integrated solutions & consulting services, and technology such as Huey AI.
NRC’s Geographic footprint
National Research Corp. primarily operates in the United States and Canada, with the majority of its revenue coming from the United States.
NRC Corporate Image Assessment
NRC Health has maintained a strong brand reputation over the past year, receiving the 2025 Best in KLAS Award for Healthcare Experience Management. The company also honored organizations with awards recognizing their dedication to patient experience and brand reputation. NRC Health's reputation capabilities have improved clients' online presence, leading to increased web traffic and appointment bookings.
Ownership
National Research Corp. has a mixed ownership structure, with institutional investors, insiders, and public/individual investors holding shares. Institutional investors own approximately 36.37% to 53.1% of the company's stock, insiders own 41.96%, and public companies and individual investors own 7.95% to 13.72%. Insider buying has been observed.
Ask Our Expert AI Analyst
Price Chart
$13.25